Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis

Merel van Nuland; Steffie Groenland; Andre M Bergman; Joris I Rotmans; Hilde Rosing; Jos H Beijnen; Alwin D R Huitema

doi:10.1016/j.clgc.2018.12.004

Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis

Merel van Nuland
, Steffie Groenland
, Andre M Bergman
, Joris I Rotmans
, Hilde Rosing
, Jos H Beijnen
, Alwin D R Huitema

Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: [email protected].
Netherlands Cancer Institute
Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	e383-e386
Number of pages	4
Journal	Clinical Genitourinary Cancer
Volume	17
Issue number	2
DOIs	https://doi.org/10.1016/j.clgc.2018.12.004
Publication status	Published - Apr 2019

Keywords

enzalutamide
hemodioalysis
metabolites
prostate cancer
renal failure

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clgc.2018.12.004

Plasma levels of EnzalutamideFinal published version, 233 KB

Cite this

@article{e3ccc460139e4c7a90cf68a8d64fc102,

title = "Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis",

keywords = "enzalutamide, hemodioalysis, metabolites, prostate cancer, renal failure",

author = "\{van Nuland\}, Merel and Steffie Groenland and Bergman, \{Andre M\} and Rotmans, \{Joris I\} and Hilde Rosing and Beijnen, \{Jos H\} and Huitema, \{Alwin D R\}",

year = "2019",

month = apr,

doi = "10.1016/j.clgc.2018.12.004",

language = "English",

volume = "17",

pages = "e383--e386",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis

AU - van Nuland, Merel

AU - Groenland, Steffie

AU - Bergman, Andre M

AU - Rotmans, Joris I

AU - Rosing, Hilde

AU - Beijnen, Jos H

AU - Huitema, Alwin D R

PY - 2019/4

Y1 - 2019/4

KW - enzalutamide

KW - hemodioalysis

KW - metabolites

KW - prostate cancer

KW - renal failure

U2 - 10.1016/j.clgc.2018.12.004

DO - 10.1016/j.clgc.2018.12.004

M3 - Article

C2 - 30626533

SN - 1558-7673

VL - 17

SP - e383-e386

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 2

ER -